[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-457226-105":59,"doc-detail-457226-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","clinical-and-imaging-manifestations-of-metastases-from-rare-sites","Clinical and Imaging Manifestations of Metastases from Rare Sites","","Metastatic tumors arising from various primary cancers can present with a broad spectrum of imaging appearances, often driven by factors such as tumor differentiation, histopathologic subtype, tumor markers, and intratumor alterations. In many clinical scenarios, combining imaging features with clinical history improves diagnostic accuracy. Despite the potential for metastases to involve almost any organ, recognition of metastases to rare sites remains limited, leading to frequent misdiagnosis or missed detection. Radiologic assessment using CT and MRI is central for diagnosis, follow-up, and differentiation from other conditions. This review synthesizes clinical, histopathological, and imaging characteristics of metastases to uncommon sites to refine organ-specific differential diagnoses and support treatment decisions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-and-imaging-manifestations-of-metastases-from-rare-sites/457226/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-and-imaging-manifestations-of-metastases-from-rare-sites/457226.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why do metastatic tumors from rare sites show diverse imaging appearances?","Question",{"text":113,"@type":114},"Their imaging appearance is mainly influenced by properties of the primary tumor, including differentiation grade, histopathologic category, tumor markers, and intratumor alterations. Clinical context can further affect diagnostic interpretation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role do CT and MRI play in evaluating rare-site metastases?",{"text":118,"@type":114},"CT and MRI are the primary modalities used to evaluate metastatic tumors and to differentiate metastases from other diseases, including primary organ tumors and inflammatory conditions. They also support detection and characterization for diagnosis and follow-up.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is accurate diagnosis of rare-site metastases critical for treatment?",{"text":122,"@type":114},"Patients with metastases generally have a worse prognosis, so correct identification is essential for appropriate management. Imaging signatures help distinguish primary carcinomas from metastases of different origins, and laboratory indicators and treatment strategies vary by cancer type.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},457226,1791069855,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review Article  \nClinical and imaging manifestations of metastases from rare sites Qian Yang\\#, Nan Chen\\#, Jie Zhang, Jiajia Su, Yong Zhang, Weipeng Yan, Shuixia Zhang  \nDepartment of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China  \nContributions: (I) Conception and design: Q Yang, N Chen; (II) Administrative support: J Zhang, J Su; (III) Provision of study materials or patients: Q Yang, N Chen; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Yong Zhang, MD; Weipeng Yan, MD; Shuixia Zhang, MD. Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 Zhuodaoquan South Road, Hongshan District, Wuhan 430079, China. Email: [383003250@qq.com](383003250@qq.com); [wptjyy@163.com](wptjyy@163.com); [154954387@qq.com](154954387@qq.com).  \nAbstract: Because various primary cancers may metastasize to rare sites, metastatic tumors have a wide variety of imaging presentations. Their imaging appearance primarily depends on features related to the primary tumor, such as the degree of tumor differentiation, histopathologic category, tumor markers, and intratumor alterations. In certain clinical situations, imaging features and clinical history may help provide a more accurate diagnosis. Metastatic tumors can involve almost any organ, but the recognition of rare sites of metastasis is insufficient. Because clinical manifestations are heterogeneous and imaging manifestations are atypical, these metastatic tumors can easily be misdiagnosed or missed. Radiology plays an important role in the diagnosis and follow-up of patients with metastatic tumors. Computed tomography (CT) and magnetic resonance imaging (MRI) are the primary imaging modalities used to evaluate metastatic tumors and to differentiate metastatic tumors from other diseases (particularly primary organ tumors or inflammatory conditions) . In this study, the principal clinical, histopathological, and imaging characteristics of metastases to uncommon sites were synthesized, with the dual aim of refining organ-specific differential diagnoses and providing a comprehensive overview of the variable manifestations of this rare condition. The marked morphologic heterogeneity of these metastases constitutes a formidable diagnostic challenge. The interpretation of various imaging findings plays a crucial role in the diagnosis and follow-up of patients with  \nmetastatic tumors at rare sites and may be critical to informing treatment decisions.  \nKeywords: Metastases; rare sites; malignant tumors; diagnosis; radiology  \nSubmitted Dec 26, 2024. Accepted for publication Sep 24, 2025. Published online Dec 11, 2025.  \ndoi: 10.21037/qims-2024-2953  \nView this article at: [https://dx.doi.org/10.21037/qims-2024-2953](https://dx.doi.org/10.21037/qims-2024-2953)  \nIntroduction  \nThe most common metastatic organs of malignant tumors are the lungs, liver, brain, and bone, whereas metastases to rare organs or sites such as the eyes, paranasal sinus, pituitary gland, parotid gland, thyroid gland, breast, heart, gallbladder, gastric colon, prostate, kidney, pancreas, spleen, uterus, bladder, etc., are rare (1) . Most cases of rare  \nsites of metastasis in the literature have been reported as individual cases, but their etiology and genetics remain unclear. Some cases of metastases have an insidious onset, with the majority of patients in case series being asymptomatic. The discovery of these metastases may be due to palpation of a mass or by accidental findings on imaging, and there is a high rate of clinical underdiagnosis.  \n© AME Publishing Company. Quant Imaging Med Surg 2026;16(1):93 | [https://dx.doi.org/10.21037/qims-2024-2953](https://dx.doi.org/10.21037/qims-","cbCaikoXy25H3dB0","https://ap.wps.com/l/cbCaikoXy25H3dB0","pdf",4739108,28,"English","# Introduction\n## Metastatic pathways and diagnostic importance\n## Clinical heterogeneity and the need for accurate imaging signatures\n## Tumor markers for monitoring recurrence and metastasis","[{\"question\":\"Why do metastatic tumors from rare sites show diverse imaging appearances?\",\"answer\":\"Their imaging appearance is mainly influenced by properties of the primary tumor, including differentiation grade, histopathologic category, tumor markers, and intratumor alterations. Clinical context can further affect diagnostic interpretation.\"},{\"question\":\"What role do CT and MRI play in evaluating rare-site metastases?\",\"answer\":\"CT and MRI are the primary modalities used to evaluate metastatic tumors and to differentiate metastases from other diseases, including primary organ tumors and inflammatory conditions. They also support detection and characterization for diagnosis and follow-up.\"},{\"question\":\"Why is accurate diagnosis of rare-site metastases critical for treatment?\",\"answer\":\"Patients with metastases generally have a worse prognosis, so correct identification is essential for appropriate management. Imaging signatures help distinguish primary carcinomas from metastases of different origins, and laboratory indicators and treatment strategies vary by cancer type.\"}]","Clinical and Imaging Manifestations of Metastases from Rare Sites | PDF",1790748657,71]